These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3532966)

  • 1. Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study.
    van Rijthoven AW; Dijkmans BA; Goei The HS; Hermans J; Montnor-Beckers ZL; Jacobs PC; Cats A
    Ann Rheum Dis; 1986 Sep; 45(9):726-31. PubMed ID: 3532966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin in rheumatoid arthritis: a double blind, placebo controlled study in 52 patients.
    Dougados M; Awada H; Amor B
    Ann Rheum Dis; 1988 Feb; 47(2):127-33. PubMed ID: 3281603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A in severe, treatment-refractory rheumatoid arthritis. A randomized study.
    Yocum DE; Klippel JH; Wilder RL; Gerber NL; Austin HA; Wahl SM; Lesko L; Minor JR; Preuss HG; Yarboro C
    Ann Intern Med; 1988 Dec; 109(11):863-9. PubMed ID: 3190040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of efficacy and acceptability of low dose cyclosporin in patients with rheumatoid arthritis.
    Dougados M; Duchesne L; Awada H; Amor B
    Ann Rheum Dis; 1989 Jul; 48(7):550-6. PubMed ID: 2673081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyclosporin on serum creatinine in patients with rheumatoid arthritis.
    Dijkmans BA; van Rijthoven AW; Goei The HS; Montnor-Beckers ZL; Jacobs PC; Cats A
    Eur J Clin Pharmacol; 1987; 31(5):541-5. PubMed ID: 3549319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
    Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
    Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis.
    Tugwell P; Bombardier C; Gent M; Bennett KJ; Bensen WG; Carette S; Chalmers A; Esdaile JM; Klinkhoff AV; Kraag GR
    Lancet; 1990 May; 335(8697):1051-5. PubMed ID: 1970370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
    Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
    Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study.
    Brackertz D; Vischer TL
    J Rheumatol; 1989 Jan; 16(1):19-23. PubMed ID: 2654391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D; Bingham CO; Tanaka Y; Agarwal P; Kurrasch R; Tak PP; Popik S
    Lancet; 2017 Mar; 389(10075):1206-1217. PubMed ID: 28215362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled study of OM-8980 in rheumatoid arthritis.
    Hauzeur JP; Appelboom T
    Rheumatol Int; 1989; 9(2):71-6. PubMed ID: 2682980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.
    Feutren G; Papoz L; Assan R; Vialettes B; Karsenty G; Vexiau P; Du Rostu H; Rodier M; Sirmai J; Lallemand A
    Lancet; 1986 Jul; 2(8499):119-24. PubMed ID: 2873396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
    Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
    Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
    Ogrendik M
    Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum creatinine levels two years later: follow-up of a placebo-controlled trial of cyclosporine in rheumatoid patients.
    Boers M; van Rijthoven AW; Goei Thè HS; Dijkmans BA; Cats A
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):371-5. PubMed ID: 3289212
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
    Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
    Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.